BioSpace News Archive

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the fourth quarter and full-year ending December 31, 2020 and provided a corporate update.

Oncology Pharma Inc. (OTC: ONPH) is pleased to announce initiation of formal drug development and preclinical planning for its lead drug product, based upon proprietary nanoemulsion technology licensed from NanoSmart Pharmaceuticals.

DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced the treatment of the first patient in a Phase 1 dose-escalation and dose-expansion study of DNX-2440

Leading the way for more than 85 years, Beckman Coulter Life Sciences proudly announces the launch of its highly anticipated CytoFLEX SRT Benchtop Sorter-- the CytoFLEX that sorts, and features expanded laser and color options for use in labs of all sizes

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the publication of preclinical results supporting the therapeutic potential of LPCN 1144 in the treatment of and non-alcoholic steatohepatitis (“NASH”) and hepatic fibrosis.

CVS Health announced it will invest $12.4 million to build 60 new units of affordable housing in south Phoenix and expand the company’s no-cost preventive health screening program, Project Health, in the greater Phoenix area as part of CVS Health’s commitment to provide $600 million over five years to address racial inequity and social determinants of health in Black communities.

Alkermes plc (Nasdaq: ALKS) announced today that it will hold a virtual Investor Day on Thursday, March 25, 2021 , beginning at 9:00 a.m. ET ( 1:00 p.m. GMT ).

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Dr. J. Joseph Kim , President and CEO, along with other members of INOVIO management, will present at the following investor conference

Arcadia Biosciences, Inc. ® (NASDAQ: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced today announced that the U.S. Patent and Trademark Office has awarded the company a patent for its high fiber resistant starch GoodWheat™

Innovatus Capital Partners, LLC (“Innovatus” or the “Firm”), an independent adviser and portfolio management firm with approximately $1.5 billion in assets under management, today announced that it has appointed Darryl Elmouchi, M.D., M.B.A., the President of Spectrum Health West Michigan, a division of Spectrum Health System, to its Life Sciences Advisory Board.